PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 6257884-2 1981 Beta-1 and beta-2 adrenergic receptor blockade were produced with atenolol and butoxamine, respectively. Atenolol 66-74 adrenoceptor beta 2 Homo sapiens 11-37 12154173-3 2002 When ISO plus the beta(1)-AR antagonist atenolol (ISO-beta(2)-AR stimulation) or 1 microM zinterol (ZIN-beta(2)-AR stimulation) increased I(Ca,L), ACh-induced inhibition of I(Ca,L) was significantly smaller, at -21 +/- 3 and -24 +/- 3 %, respectively. Atenolol 40-48 adrenoceptor beta 2 Homo sapiens 54-64 7504142-4 1993 There was no significant difference in total or subtype beta-adrenoceptor densities, but basal and isoproterenol stimulated adenylate cyclase activity were significantly greater in the atenolol-treated group, as was the intrinsic activity of the beta 2-adrenoceptor partial agonist procaterol, suggesting that chronic therapy with xamoterol does not downregulate human cardiac beta-adrenoceptors in vivo. Atenolol 185-193 adrenoceptor beta 2 Homo sapiens 246-265 3037216-2 1987 The beta 1-selective antagonists atenolol and LK 203-030 inhibited specific [125I]-(-)-cyanopindolol binding according to a one binding site model with low affinity in nearly all subjects, pointing to a homogeneous beta 2-adrenoceptor population. Atenolol 33-41 adrenoceptor beta 2 Homo sapiens 215-234 2866785-3 1985 Atenolol produced significantly less reduction of essential and isoprenaline-induced tremor than the non-selective drugs, confirming the importance of beta 2-adrenoceptor blockade in these effects. Atenolol 0-8 adrenoceptor beta 2 Homo sapiens 151-170 17003101-7 2007 Furthermore, atenolol and ICI 118,551, a beta1- and beta2-adrenoceptor antagonist, respectively, reversed the stimulatory action of nicotine on the expression of PKC, ERK1/2 phosphorylation, and COX-2 together with cell proliferation. Atenolol 13-21 adrenoceptor beta 2 Homo sapiens 52-70 15687340-6 2005 The beta2-AR was stimulated with two doses of salbutamol (50 and 100 ng/kg fat-free mass per minute) after blockade of the beta1-adrenergic receptors with atenolol. Atenolol 155-163 adrenoceptor beta 2 Homo sapiens 4-12 1971535-4 1990 There was an enhanced responsiveness to (-)epinephrine (atenolol treated: -log M EC50, 7.57 +/- 0.07; non-beta-blocker treated: -log M EC50, 6.77 +/- 0.17; p less than 0.001), and the relative importance of beta 2-adrenoceptor stimulation was increased for both (-)norepinephrine and (-)epinephrine. Atenolol 56-64 adrenoceptor beta 2 Homo sapiens 207-226 2713221-0 1989 Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist. Atenolol 11-19 adrenoceptor beta 2 Homo sapiens 75-94 2575521-6 1989 These results show that beta 2-adrenoceptor blockade by atenolol is a dose-dependent phenomenon, which may be measured by the attenuation of salbutamol-induced hypokalaemia. Atenolol 56-64 adrenoceptor beta 2 Homo sapiens 24-43 2575521-7 1989 However, beta 2-adrenoceptor blockade by atenolol 200 mg was less than that by propranolol 40 mg. Atenolol 41-49 adrenoceptor beta 2 Homo sapiens 9-28 25026350-1 2014 CONTEXT: Propranolol, atenolol, and ICI118,551 are non-selective beta-adrenergic receptor (AR), beta1-AR, and beta2-AR antagonists, respectively. Atenolol 22-30 adrenoceptor beta 2 Homo sapiens 110-118 21963428-6 2012 In contrast, pretreatment of cells with a third beta(2)AR antagonist, atenolol resulted in an increase in OTR-mediated ERK1/2 activation. Atenolol 70-78 adrenoceptor beta 2 Homo sapiens 48-57